|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/609 | |||
| C07C 235/46 | |||
| C07C 235/60 | |||
| A61K 9/00 | |||
| A61K 31/197 | |||
| A61K 31/198 |
| (11) | Number of the document | 3572086 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19180925.0 |
| Date of filing the European patent application | 2005-05-06 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 569476 P | 2004-05-06 | US | |
| 619418 P | 2004-10-15 | US |
| (72) |
Levchik, Halina, US
Singh, Brahma, US
Majuru, Shingai, US
Harris, Jamila, US
|
| (73) |
Novo Nordisk North America Operations A/S ,
Novo Alle 1, 2880 Bargsvaerd,
DK
|
| (54) | CRYSTALLINE POLYMORPHIC FORMS OF MONOSODIUM N-[8-(2-HYDROXYBENZOYL)AMINO]CAPRYLATE |
| CRYSTALLINE POLYMORPHIC FORMS OF MONOSODIUM N-[8-(2-HYDROXYBENZOYL)AMINO]CAPRYLATE |